Enrisone SR Sustained-Release Tablet (Eperisone Hydrochloride)

Adult dose

This medication is in a sustained-release tablet form and should be taken whole without crushing, splitting, or chewing. Adults take 1 tablet (75 mg of eperisone hydrochloride) orally after meals, twice daily. The dosage may be adjusted appropriately based on age and symptoms.

This medication should not be used by patients with known allergies to this drug or by patients with severe myasthenia gravis. Patients with a history of drug allergies or those with liver dysfunction should use this medication cautiously, as liver function may worsen. During treatment, serious allergic reactions or symptoms such as skin rash, fever, itching, blisters, eye redness, and stomatitis may occur, in which case treatment should be discontinued immediately and medical assistance sought. Additionally, various side effects such as headache, dizziness, drowsiness, indigestion, nausea, vomiting, constipation, diarrhea, and abdominal pain may occur, so it is important to monitor your condition closely. During treatment, symptoms such as weakness, staggering, and drowsiness may appear, so it is advisable to reduce the dosage or discontinue use if these symptoms occur. Drowsiness and reduced concentration may occur, so activities such as driving or operating hazardous machinery should be avoided during treatment. Women who are pregnant or may become pregnant should only use this medication after consulting with a physician, as the safety profile has not been established, weighing the treatment benefits against the risks. Breastfeeding women should ideally avoid this medication, and if unavoidable, it is recommended to discontinue breastfeeding while on treatment. Safety in children has not been sufficiently established, thus special caution is needed when administering to children. Elderly patients may have reduced physiological function, so dosage adjustments and careful monitoring are necessary.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, shock, anaphylactic reactions, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe fever, severe rash, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, extreme lethargy, jaundice, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision abnormalities, paralysis, markedly reduced urination, severe generalized swelling accompanied by elevated blood pressure.

Mild side effects

• Redness
• itching
• swelling
• stomatitis
• eye redness
• nausea
• vomiting
• loss of appetite
• abdominal discomfort
• dry mouth

This medicine should be stored in a tightly sealed container to avoid exposure to air or moisture, and the storage temperature should be maintained at room temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication safely.

Appearance

White to almost white round sustained-release film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle